These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6787574)

  • 1. The influence of a new antiarrhythmic drug, Craviten (M-71) on coronary flow.
    Banaszkiewicz W; Chodera A
    Pol J Pharmacol Pharm; 1980; 32(6):849-53. PubMed ID: 6787574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of Craviten (M-71).
    Maj J; Kulig D; Myśliwiec D; Bugielska Z; Tomsa E; Zaczyńska-Kostrakiewicz M
    Pol J Pharmacol Pharm; 1980; 32(6):855-75. PubMed ID: 7243682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of a new antiarrhythmic drug, Craviten (M-71) on the circulatory system in cats.
    Banaszkiewicz W; Chodera A
    Pol J Pharmacol Pharm; 1980; 32(6):841-8. PubMed ID: 7243681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters.
    Ernest K
    Pol J Pharmacol Pharm; 1975; 27(4):381-98. PubMed ID: 1166019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of calcium-induced repolarization heterogeneity as a mechanism of nitroglycerin's antiarrhythmic action.
    Zhao SX; Lee LM; Nearing BD; Busso VO; Kwaku KF; Verrier RL
    J Cardiovasc Pharmacol; 2006 Aug; 48(2):22-9. PubMed ID: 16954817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacology of a new anti-angina preparation, nonachlazin].
    Kaverdina NV; Markova GA
    Farmakol Toksikol; 1975; 38(2):173-7. PubMed ID: 1227883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of some antidepressant drugs on cardiac function. IV. Influence of blood supply of the heart in situ.
    Banaszkiewicz W; Mrozikiewicz A
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):477-82. PubMed ID: 999463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new antiarrhythmic drug.
    Rydén L
    Acta Med Scand Suppl; 1974; 569():1-40. PubMed ID: 4533723
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proceedings: Influence of nitroglycerine and coronary vasodilatators on the regional myocardial circulation in coronary heart disease].
    Mösslacher H; Slany J; Imhof H
    Z Kardiol; 1974; 0(Suppl 1):34. PubMed ID: 4215253
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
    Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a new antiarrhythmic drug: Craviten (M-71) on the ATP level in heart muscle slices in vitro.
    Gumińska M; Kedryna T; Marchut E; Eckstein M
    Pol J Pharmacol Pharm; 1980; 32(6):877-82. PubMed ID: 7243683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological study of new ethylenediamine derivatives with antiarrhythmic activity].
    Boni P; Bacciarelli C
    Farmaco Sci; 1974 Dec; 29(12):923-35. PubMed ID: 4442581
    [No Abstract]   [Full Text] [Related]  

  • 13. Central action of Craviten (M-71).
    Maj J; Sowińska H; Baran L; Mogilnicka E; Przewłocka B
    Pol J Pharmacol Pharm; 1980; 32(6):823-32. PubMed ID: 7243679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Venous use of nitroglycerin in acute myocardial infarct].
    Terzieva L
    Vutr Boles; 1984; 23(6):8-13. PubMed ID: 6442491
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of the effects of bepridil, dipyridamole, and propranolol on the cardiac activity and the coronary venous debt in anesthetized dogs].
    Michelin MT; Cheucle M; Duchene-Marullaz P
    Therapie; 1977; 32(4):485-99. PubMed ID: 605426
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the modification of circulatory depressant effect of bradycardia-inducing drugs].
    Grisk A; Stremmel D
    Acta Biol Med Ger; 1968; 20(6):805-23. PubMed ID: 5723838
    [No Abstract]   [Full Text] [Related]  

  • 17. Phasic myocardial blood content. An experimental study on effects of hypoxaemia, ischaemia and coronary drugs.
    Virtanen KS
    Ann Clin Res; 1974; 6(0):1-51. PubMed ID: 4210704
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of nitroglycerin, nifedipine and dipyridamole on the left coronary blood flow patterns and the myocardial blood flow in the left ventricle (author's transl)].
    Hirano T; Maeda T; Morishita T; Shinohara S; Kawata F; Kinjo M
    Kokyu To Junkan; 1980 Sep; 28(9):1021-9. PubMed ID: 6782632
    [No Abstract]   [Full Text] [Related]  

  • 19. [Circulatory action and adverse effects of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog and cat].
    Poppe H; Femmer K; Kaverina NV; Lyskovzev VV; Grigoreva JK; Mazievskij DD
    Pharmazie; 1985 Dec; 40(12):857-61. PubMed ID: 3841603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.